Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Pharmacology and Pain Drug Development SME

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract opportunity through the Department of Health and Human Services Omas Strategic Buying Center seeks a subject matter expert in pharmacology and pain to support prime contractors on NIH HEAL Initiative projects. The selected expert will provide executive-level guidance on small molecule and biologic therapeutics, focusing on drug discovery and pharmacology-related trials for nervous system conditions. Key responsibilities include performing strategic programmatic reviews, evaluating milestones, and providing mentorship. The role requires the delivery of strategic recommendations and milestone evaluations through formal committee reports. Performance will take place in Bethesda, and the opportunity is categorized under NAICS code 541714. Interested parties should note the response deadline of November 3, 2026.

General Info

Pharmacology expert needed for NIH HEAL Initiative therapeutics guidance in Bethesda by November 2026.

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

Bethesda, MD, USA

Set-Aside

NONE

Documents

This scope was carved out of 7571PSQ00013.

The full solicitation package (6 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Senior Advisor 2 for Biological Therapeutics Development to act as External Oversight Committee (EOC) Subject Matter Expert (SME) Services.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Omas Strategic Buying Center - Professional Services
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Provides executive-level subject matter expertise in pharmacology and pain for prime contractors on NIH HEAL Initiative projects. Performs strategic programmatic reviews, milestone evaluation, and mentorship for small molecule and biologic therapeutics. Evaluates pharmacology-related trials and drug discovery for nervous system conditions. Delivers strategic guidance, programmatic recommendations, and milestone evaluations via committee reports.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
RFI Alzheimer’s Research Program (AZRP) Public
Solicitation # HT9427RFI2027AZRP
The Defense Health Agency, through the Congressionally Directed Medical Research Programs, has issued a Request for Information under solicitation number HT9427RFI2027AZRP to gather strategic feedback for the fiscal year 2027 Alzheimer’s Research Program. The primary objective is to identify research focus areas and funding opportunities aimed at mitigating the impact of Alzheimer's and related dementias, specifically those associated with traumatic brain injury, military service, and diverse risks. The program seeks to improve the quality of life for Service Members, Veterans, and their families by funding solution-oriented research, including the development of digital and blood-based biomarkers for early diagnosis and the creation of precision prevention strategies. This action is strictly for information and planning purposes and does not constitute a formal solicitation, request for proposals, or request for quotations. No contracts will be awarded based on this announcement, and FY27 funds have not yet been appropriated. Interested parties from academia, industry, non-profit organizations, and federal agencies are invited to provide feedback via Survey Monkey by December 4, 2026. Respondents are cautioned not to submit proprietary or sensitive information through the survey portal as it cannot be protected. The effort is categorized under NAICS code 541714 and is managed by the Department of Defense in Fort Detrick, Maryland.
Defense Health Agency

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
New
Federal
Traumatic Brain Injury and Psychological Health Research Program Public Request for Information
Solicitation # HT9427RFI2027TBIPHRP
The Defense Health Agency, under the Department of Defense and the Congressionally Directed Medical Research Programs, has issued a Request for Information under solicitation number HT9427RFI2027TBIPHRP. This action is strictly for strategic planning and is not a formal solicitation, request for proposals, or request for quotations. The primary objective is to gather feedback from academia, industry, non-profit organizations, and the public to inform the research focus areas and funding opportunities for the fiscal year 2027 Traumatic Brain Injury and Psychological Health Research Program. The program aims to optimize the prevention, assessment, and treatment of psychological health conditions and traumatic brain injuries to benefit Service Members, Veterans, and the general public. Interested parties are asked to provide input on research gaps and funding priorities, specifically regarding the prevention, screening, diagnosis, and treatment of these conditions. Responses must be submitted via Survey Monkey by December 11, 2026. Because the government cannot protect proprietary or sensitive information submitted through the survey platform, such data should not be included. This inquiry does not commit the program to incorporating the feedback into future funding opportunities, and no contract will be awarded based on this specific announcement. All inquiries regarding this RFI should be directed to Patrick M. Younkins.
Defense Health Agency

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
New
Federal
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Solicitation # 75A50126R00001_RFP_NPIVS_27
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. The objective is to maintain a permanent readiness posture against high-threat influenza and other viruses with pandemic potential. Selected contractors will provide vaccines, antigens, and adjuvants, and generate necessary analytical, nonclinical, clinical, and chemistry, manufacturing, and controls data for FDA submission to support rapid regulatory decisions. To be eligible, offerors must produce vaccines against influenza strains with pandemic potential and demonstrate successful manufacturing experience by holding a U.S. influenza vaccine license or having submitted a Biologics License Application for a seasonal or pandemic influenza vaccine. The government intends to award contracts to four offerors based on the Highest Technically Rated Offerors with a Fair and Reasonable Price methodology. Evaluation factors include capabilities, past performance, and price, with capabilities being the most significant. The contract structure consists of a 60-month base period and a 60-month option period, with a minimum guarantee of 50,000 dollars. Key requirements include the development of comprehensive manufacturing, business continuity, and supply continuity plans, as well as adherence to strict ASPR security and FDA CGMP standards. Performance will be managed through individual task orders and BPA call orders, with invoicing conducted quarterly via the Department of Treasury Invoice Processing Platform.
Barda - Aspr / Daappo / Barda Dcma

POSTED

2 days ago

DEADLINE

in 23 days
View Details
NAICS: 541714
New
Federal
Quantitative Analysis of Longitudinal MR Images
Solicitation # 75N98027R00005
Solicitation 75N98027R00005 is a Sources Sought notice issued by the National Institute on Aging (NIA) to identify qualified companies capable of performing quantitative analysis of longitudinal Magnetic Resonance (MR) images. The project supports the Baltimore Longitudinal Study of Aging (BLSA) by processing 300 newly acquired MR datasets to characterize brain aging trajectories and identify predictors of cognitive decline and Alzheimer’s disease. The selected contractor will provide specialized, non-commercial services to deliver global and regional tissue volumes, lesion quantification, and machine learning-derived scores, such as SPARE-AD, while ensuring longitudinal consistency with data acquired since 1994. The anticipated contract will be a firm fixed price award with a period of performance of one year. Key deliverables include quantitative volumetric results, intermediate processing files, and registration maps for PET overlay, submitted every six months, concluding with a final report. Technical requirements emphasize the use of established image analysis tools and adherence to FISMA/FedRAMP-aligned data security controls to protect participant confidentiality. Interested respondents must submit a capability statement by November 9, 2026, to Contract Specialist Sneha Singh. The submission must be limited to ten pages and include the company's Unique Entity ID, NAICS code 541714, professional qualifications of personnel, and any applicable GSA schedules or government-wide acquisition contracts. Small businesses are encouraged to respond to this market research effort to help the government determine the appropriate acquisition method.
National Institutes Of Health Olao

POSTED

5 days ago

DEADLINE

in 12 days
View Details
NAICS: 541714
New
Federal
Q--AMPLICON SEQUENCING SERVICES
Solicitation # 140G0226Q0047
The Department of the Interior, through the USGS OAG Denver Acquisition Branch, is soliciting quotations for a Blanket Purchase Agreement (BPA) to provide next-generation amplicon sequencing services for the Michigan Bacteriological Research Laboratory. The agreement has a not-to-exceed value of $250,000 over a five-year period of performance from September 17, 2026, to September 16, 2031. The scope of work includes non-personal services such as library preparation for 16S V4 amplicon sequencing, library pooling, and sequencing using Illumina MiSeq or AVITI platforms to support research on bacterial pathogens, antibiotic resistance, and microbial ecology. Key deliverables include demultiplexed raw data and reporting metrics, with a required delivery turnaround of 60 business days from sample receipt. Award decisions will be based on technical and priced factors, with non-priced factors carrying significantly more weight. Technical evaluations will focus on the contractor's on-site equipment, personnel experience, quality control procedures, business establishment, and a capabilities narrative. Offerors must also provide two customer references from the last five years. The contract is subject to various federal regulations, including specific security prohibitions regarding certain telecommunications equipment and the requirement for electronic invoicing through the Invoice Processing Platform System. Quotations are due by November 5, 2026, and must be submitted via email to the primary point of contact.
Ofc Of Acquisition Grants-Denver

POSTED

6 days ago

DEADLINE

in 8 days
View Details
NAICS: 541714
New
Federal
ARPA-H Emerging Health Innovators (EHI) Initiative
Solicitation # ARPA-H-SOL-26-150
The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) initiative, solicitation ARPA-H-SOL-26-150, seeks to identify and engage early-career investigators to develop cutting-edge biomedical, health, and community-engaged research. This opportunity is open to researchers from academic, nonprofit, and industry organizations, provided the Principal Investigator is within eight years of completing their first terminal degree. The initiative covers 16 specific topic areas, including AI in life sciences, brain stimulation, and human tissue platforms. Awards are issued as Other Transaction (OT) agreements, which are not subject to the Federal Acquisition Regulation (FAR). The selection process is a two-step submission involving an initial anonymized Solution Summary and a subsequent Full Proposal for selected candidates. Successful awards have a total value not to exceed 1,050,000 dollars over a three-year period, consisting of a 24-month base period capped at 700,000 dollars and an optional 12-month Director's Award period capped at 350,000 dollars. Payments are structured as fixed payments triggered by the completion of 12 discrete, measurable milestones. Full proposals are evaluated based on technical merit, innovativeness, feasibility, alignment with the ARPA-H mission to accelerate health outcomes, and price reasonableness. Administrative requirements include mandatory registration in SAM.gov and the use of the ARPA-H Solutions site for all submissions. Proposers must adhere to strict formatting templates for technical and management proposals, milestone schedules, and national policy requirements, including disclosures regarding organizational conflicts of interest and research security. Performance is monitored through a formal inspection and acceptance process where the government reviews deliverables within 14 calendar days. The tentative award start date is June 30, 2027, with full proposals due by February 10, 2027.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

6 days ago

DEADLINE

in 4 months
View Details
NAICS: 541714
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Solicitation # W911SR-26-R-HEAL
The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is establishing the Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) ecosystem. This continuous, open announcement seeks to build a network of pre-qualified partners to accelerate the development, testing, and fielding of next-generation medical defense solutions. The program focuses on two primary pillars: host-targeted resilience, which targets critical host systems like neurological and respiratory pathways to enhance physiological protection, and threat-targeted neutralization, which focuses on broad-spectrum countermeasures for prophylaxis and acute treatment. Priority is given to candidates designed for austere environments, featuring environmental stability without cold-chain reliance and simplified administration routes such as oral or intranasal delivery. The government is inviting two types of participants: MCM Development Collaborators, ranging from Phase I products through FDA licensure, and MCM Development Support Collaborators, such as CROs and CDMOs specializing in preclinical testing, cGMP manufacturing, and regulatory submissions. Interested parties must submit a white paper of no more than five pages detailing their product descriptions, efficacy data, regulatory status, and manufacturing capabilities. Acceptance into the PBA enables the subsequent award of project orders under the authority of 10 U.S.C sections 4021, 4022, and 4023. These agreements are not subject to the Competition in Contracting Act of 1984. All prospective awardees must be registered in the System for Award Management (SAM) database to receive payment.
W6QK Acc-Apg

POSTED

7 days ago

DEADLINE

N/A
View Details

More opportunities from Department Of Health And Human Services → Omas Strategic Buying Center - Professional Services

Same awarding agency

NAICS: 812930
New
Federal
PARKING SERVICES IN SUPPORT OF THE NATIONAL INSTITUTES OF HEALTH (NIH)
Solicitation # 7571PS27Q00010
The National Institutes of Health (NIH) has issued a Small Business Sources Sought Notice under solicitation 7571PS27Q00010 to identify qualified small business capabilities for comprehensive parking services at the Bethesda campus and various off-campus leased locations in the DC Metro area. The scope of work includes managing valet and stack-parking, facilitating self-parking, and conducting daily vehicle counts to support over 20,000 employees, visitors, and medical patients. Key operational requirements include the daily coordination of up to 1,000 vehicles, maintaining a two-minute turnaround for vehicle returns, and the daily inspection and repair of approximately 105 parking meters and EV charging stations. The anticipated period of performance is a 60-month term, consisting of a 12-month base period starting March 1, 2027, followed by four optional 12-month extensions. The contract requires specialized staffing for patient valet operations compliant with CRIS and HIPAA regulations, on-site project management, and adherence to FAR 52.204-9 for personnel identity verification. Performance is monitored by a Contracting Officer’s Representative through strict reporting of vehicle accidents, customer complaints, and daily permit inspections. Interested small businesses must submit their capabilities statement, business size status, and responses to technical questionnaires to Nick Niefeld by November 6, 2026.
Parking Lots and Garages

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 541690
New
Federal
Senior Advisor 2 for Biological Therapeutics Development to act as External Oversight Committee (EOC) Subject Matter Expert (SME) Services.
Solicitation # 7571PSQ00013
Solicitation 7571PSQ00013 is a competitive request for quote for an executive-level Senior Advisor 2 to serve as a Subject Matter Expert (SME) for the NIH Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) and the HEAL Initiative. The selected contractor will act as a member of the External Oversight Committee (EOC), providing strategic guidance, programmatic reviews, and mentorship to advance the discovery and development of safe, non-addictive therapeutics for pain and nervous system conditions. The primary goal is to support the advancement of at least two novel therapeutics into clinical trials within five years. This is a small business set-aside under NAICS code 541690. The contract is structured as a fixed-price purchase order with a base period from November 5, 2026, to November 4, 2027, and two optional one-year extensions, for a total potential duration of three years. The government anticipates approximately 50 labor hours per year, with an option for an additional 50 hours, and may reimburse up to 2,000 dollars in annual travel expenses per consultant. Performance will primarily occur at the contractor's site, with occasional visits to Bethesda, Maryland. Award decisions will be based on best value, with technical qualifications—specifically professional expertise in pharmaceutical development and pain, educational credentials, and collaborative experience—weighted significantly more than price and past performance. Proposed key personnel must be employees of the quoter by the start of performance and are subject to a salary cap based on the Executive Schedule, Level II. All quotes must be submitted by November 3, 2026, and require active registration in the System for Award Management.
Other Scientific and Technical Consulting Services

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 541690
New
Federal
Senior Advisor Subject Matter Expert (SME) with Patient Advocacy Expertise for the NINDS Ultra-rare Gene-based Therapy (URGenT) Network
Solicitation # 7571PS27Q00015
The Department of Health and Human Services, through the National Institute of Neurological Disorders and Stroke (NINDS), is soliciting a Firm Fixed Price purchase order for an executive-level Senior Advisor Subject Matter Expert (SME) with specialized expertise in Patient Advocacy. The selected contractor will serve on the Ultra-rare Gene-based Therapy (URGenT) External Counselor Board (ECB) to provide strategic guidance and technical feedback on drug discovery and development projects, specifically focusing on accelerating therapeutics for ultra-rare neurological diseases. Key responsibilities include recommending solutions for programmatic challenges, evaluating project milestones, and providing guidance on biologic drug discovery and gene-based therapy trials. The acquisition is a total set-aside for small business concerns under NAICS code 541690. The anticipated period of performance consists of a base year from November 6, 2026, to November 5, 2027, with two subsequent one-year options, totaling a maximum duration of three years. The government estimates a base effort of 50 labor hours per year, with an option for an additional 50 hours, and may reimburse up to 2,000 dollars in annual travel expenses per consultant. Awards will be based on best value, with technical qualifications regarding pharmaceutical development and pain expertise weighted significantly more than price and past performance. All quotes must be submitted by 1:00 PM Eastern Time on November 2, 2026, to the designated Contracting Officer.
Other Scientific and Technical Consulting Services

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 541690
New
Federal
Senior Advisor 2 for the Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative to act as Subject Matter Expert (SME) with Pharmaceutical Development and Pain Expertise
Solicitation # 7571PSQ00012
The National Institutes of Health (NIH) is seeking a highly experienced, executive-level Senior Advisor 2 to serve as a Subject Matter Expert (SME) in Pharmacology and Pain for the Helping to End Addiction Long-term (HEAL) Initiative. The selected contractor will join the HEAL External Oversight Committee to provide strategic guidance, technical expertise on drug discovery and development projects, and mentorship to the HEAL executive team. Key responsibilities include reviewing program operations, recommending pharmacology-related trial advancements, and evaluating project milestones to accelerate the development of non-addictive analgesic therapeutics. This is a small business set-aside acquisition under NAICS code 541690, utilizing a fixed-price purchase order. The base period of performance is from November 5, 2026, to November 4, 2027, with two subsequent one-year option periods extending the total duration to three years. The government anticipates 50 labor hours per year, with an option for an additional 50 hours, and may reimburse up to $2,000 in annual travel expenses per consultant. Award will be based on best value, with technical qualifications—specifically professional experience in pharmaceutical development and pain expertise, educational credentials, and collaborative team experience—weighted as significantly more important than price and past performance. Applicants must be registered in the System for Award Management (SAM) and submit their quotes by 12:00 PM Eastern Time on November 3, 2026. Proposed key personnel must be employees of the quoter by the start of the contract and are subject to salary limitations based on the Executive Schedule, Level II.
Other Scientific and Technical Consulting Services

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 541690
New
Federal
Senior Advisor 2 Services for the NINDS Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative for the Pain Therapeutics Development Program (PTDP) External Oversight Committee (EOC) Subject Matter Expert (SME) Services
Solicitation # 7571PS27Q00011
The National Institutes of Health (NIH) is soliciting quotes for a highly experienced, executive-level Senior Advisor 2 to serve as a Subject Matter Expert (SME) in Pharmacology and Pain. This role supports the NINDS Helping to End Addiction Long-term (HEAL) Initiative's Pain Therapeutics Development Program (PTDP) by serving on the External Oversight Committee (EOC). The selected contractor will provide strategic guidance, technical feedback on drug discovery and development projects, and mentorship to the HEAL executive team to accelerate the creation of non-addictive analgesic therapeutics. This acquisition is set aside for small business concerns under NAICS code 541690. The contract is structured as a fixed-price labor hour purchase order with a base period from November 5, 2026, to November 4, 2027, and two subsequent one-year options. The government anticipates an estimated 50 labor hours per year, with an option for an additional 50 hours, and may reimburse up to 2,000 dollars in annual travel expenses per consultant. Performance is primarily at the contractor's site, with occasional requirements at government facilities in Bethesda, Maryland. Evaluation will be based on best value, with technical qualifications weighted significantly more than price and past performance. The technical evaluation focuses on the SME's professional experience in pharmaceutical development, educational credentials, and collaborative team experience. Proposals must include resumes, letters of commitment, and a specific narrative demonstrating how personnel meet the qualifications. All quotes must be submitted by 12:00 PM Eastern Time on November 3, 2026, and offerors must be actively registered in the System for Award Management (SAM).
Other Scientific and Technical Consulting Services

POSTED

1 day ago

DEADLINE

in 6 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS